[Clinical studies on norfloxacin in the field of pediatrics]. 1990

T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
Department of Pediatrics, Kobe City General Hospital.

We studied clinical effects of norfloxacin (NFLX, AM-715) tablets. The results we found are summarized as follows: 1. Ten patients with 5 diseases were medicated with 7.0-14.8 mg/kg of the drug 3 times daily for 6-8 days. They consisted of one-each with tonsillitis, pharyngitis, bronchitis, 4 with Campylobacter enteritis, 3 with other enteritis. Clinical responses to the treatment were excellent in 8, good in 1 and fair in 1, with an efficacy rate of 90%. Bacteriologically, of 9 isolates for which changes in populations were followed, 6 were eradicated and 3 remained unchanged, with an eradication rate of 66.7%. 2. No. adverse reactions nor abnormal laboratory test values attributable to the drug were observed. 3. These results suggest that this new quinolone drug may be useful, against bacterial infections in children 6 years and older.

UI MeSH Term Description Entries
D008297 Male Males
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
May 1990, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
May 1990, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
May 1990, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
May 1990, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
September 1990, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
January 1995, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
July 1985, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
January 1983, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
November 1982, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and K Okura, and Y Kobayashi
May 1990, The Japanese journal of antibiotics,
Copied contents to your clipboard!